ReviewCurrent hematologic malignancy reports2018

Anti-CD19 Chimeric Antigen Receptor T Cell Therapies: Harnessing the Power of the Immune System to Fight Diffuse Large B Cell Lymphoma.

Robert Havard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.